scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00223-008-9126-5 |
P698 | PubMed publication ID | 18470550 |
P50 | author | Maria Luisa Brandi | Q29839820 |
P2093 | author name string | Maurizio Rossini | |
Sergio Ortolani | |||
Sandro Giannini | |||
Silvano Adami | |||
Bruno Frediani | |||
Gerolamo Bianchi | |||
BONTURNO study group | |||
Ombretta DiMunno | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 341-347 | |
P577 | publication date | 2008-05-10 | |
P1433 | published in | Calcified Tissue International | Q5018771 |
P1476 | title | Determinants of bone turnover markers in healthy premenopausal women | |
P478 | volume | 82 |
Q52647974 | Actions of pituitary hormones beyond traditional targets. |
Q37184262 | Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study |
Q39934392 | Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. |
Q34360040 | Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study |
Q55002406 | Bone Turnover Status: Classification Model and Clinical Implications. |
Q48169216 | Bone markers in polycystic ovary syndrome: A multicentre study. |
Q51359928 | Bone metabolism in patients with anorexia nervosa and amenorrhoea. |
Q50867809 | Bone remodelling is reduced by recovery from iron-deficiency anaemia in premenopausal women. |
Q39517981 | Bone turnover marker reference intervals in young females. |
Q38016073 | Bone turnover markers: use in osteoporosis |
Q53388020 | Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women. |
Q36491529 | Does estrogen play a role in response to adjuvant bone-targeted therapies? |
Q35144713 | Effects of diosgenin on myometrial matrix metalloproteinase-2 and -9 activity and expression in ovariectomized rats |
Q36242941 | Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer |
Q34171858 | Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state |
Q36692024 | Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women |
Q36056975 | Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review |
Q64075023 | FSH Beyond Fertility |
Q43714450 | Further evidence that FSH causes bone loss independently of low estrogen |
Q35025198 | Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults |
Q47116443 | Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency |
Q58903546 | Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism |
Q37823835 | Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. |
Q33572610 | National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges |
Q38017609 | Osteoporosis in young adults: pathophysiology, diagnosis, and management. |
Q38104738 | Osteoporosis treatment: why ibandronic acid? |
Q37048294 | Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture |
Q90450569 | Reference Intervals for Bone Turnover Markers in Korean Healthy Women |
Q34623146 | Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania |
Q45155246 | Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China |
Q42910767 | Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men |
Q38921875 | The Utility of Biomarkers in Osteoporosis Management. |
Search more.